RxDoctor Payments Data

Wayne Clark, MD

Neurology · Portland, ORNPI 1356357958

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in OR, where the typical reported total is $437.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$743,514in research payments, 2019–2025

Across 455 payments — averaging $1634.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$313K
  • Genentech, Inc.$190K
  • E.r. Squibb & Sons, L.L.C.$122K
  • Ceribell, Inc.$46K
  • Daiichi Sankyo Inc.$25K
  • Merck$23K
  • plus $24K from 3 others

How this compares

$0 in reported general payments places this provider in the 20th percentile of 228 neurology providers in Oregon.

See all neurology providers in Oregon

Medicare billing

Part B allowed, 2024
$76,197
Medicare patients
201
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$10,924
Cilostazol11$239
ClopidogrelClopidogrel Bisulfate14$71

Paid to pharmacies, not to this prescriber.

Other neurology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →